Why is QuidelOrtho (QDEL) a Good Stock to Invest in?
ClearBridge Investments, an investment management company, released its “ClearBridge All Cap Value Strategy” third quarter 2023 investor letter. A copy of the same can be downloaded here.
Quidelortho Corp (QDEL)
Market is closed
News
- First
- << Previous
- 21 - 30
- Next >>
QuidelOrtho Corporation (NASDAQ:QDEL) Q3 2023 Earnings Call Transcript
Operator: Welcome to the QuidelOrtho Third Quarter 2023 Financial Results Conference Call and Webcast. At this time, all participant lines are in a listen-only mode.
Should You Add QuidelOrtho (QDEL) to Your Portfolio?
ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Value Strategy” second quarter 2023 investor letter. A copy of the same can be downloaded here.
QuidelOrtho Corporation (NASDAQ:QDEL) Q2 2023 Earnings Call Transcript
Operator: Welcome to the QuidelOrtho Second Quarter 2023 Financial Results Conference Call and Webcast. At this time, all participant lines are in a listen-only mode.
QuidelOrtho Corporation (NASDAQ:QDEL) Q1 2023 Earnings Call Transcript
Operator: Welcome to the QuidelOrtho First Quarter 2023 Financial Results Conference Call and Webcast. At this time, all participant lines are in a listen-only mode.
17 High Growth Low PE Stocks
The optimism seen in financial markets during the start of 2023 is fading as retail sales data, CPI numbers and jobs report collectively dashed any hopes that the Federal Reserve might stop increasing...
13 Most Undervalued Healthcare Stocks To Buy According To Hedge Funds
In this article, we will take a look at the 13 most undervalued healthcare stocks to buy according to hedge funds.
12 High Growth Healthcare Stocks to Buy
The healthcare sector proved its mettle in 2022.
QuidelOrtho Corporation (NASDAQ:QDEL) Q4 2022 Earnings Call Transcript
Operator: Welcome to the QuidelOrtho Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast. At this time, all participant lines are in listen-only mode.
5 Best Healthcare Stocks For the Long Term
AbCellera Biologics Inc. (NASDAQ:ABCL) is a Canadian biotech company. AbCellera Biologics Inc. (NASDAQ:ABCL) is operating in the human antibodies space. Earlier in December AbCellera Biologics Inc.
- First
- << Previous
- 21 - 30
- Next >>
Billionaire Hedge Funds
